Get started
ONO Pharmaceutical Co., Ltd.ONO Pharmaceutical Co., Ltd.ONO Pharmaceutical Co., Ltd.

ONO Pharmaceutical Co., Ltd.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ON4 chart


Full chart

ON4 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.64 B‬ EUR
Dividend yield (indicated)
4.70%
Price to earnings Ratio (TTM)
18.312
Basic EPS (TTM)
0.538 EUR
Net income (FY)
‪308.37 M‬ EUR
Revenue (FY)
‪3.00 B‬ EUR
Shares float
‪329.13 M‬
Beta (1Y)
0.34

Employees


Employees (FY)
‪4.29 K‬
Change (1Y)
+434 +11.26%
Revenue / Employee (1Y)
‪699.78 K‬ EUR
Net income / Employee (1Y)
‪71.93 K‬ EUR

About ONO Pharmaceutical Co., Ltd.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Gyo Sagara
Website
ono.co.jp
Headquarters
Osaka
Founded
1947
ISIN
JP3197600004
FIGI
BBG000C4Q9Y2
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.

Check out other big names from the same industry as ON4.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ON4 news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ON4 is 9.650 EUR — it has decreased by −1.03% in the past 24 hours. Watch ONO Pharmaceutical Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange ONO Pharmaceutical Co., Ltd. stocks are traded under the ticker ON4.
ON4 stock has risen by 3.23% compared to the previous week, the month change is a 3.23% rise, over the last year ONO Pharmaceutical Co., Ltd. has showed a −23.41% decrease.
We've gathered analysts' opinions on ONO Pharmaceutical Co., Ltd. future price: according to them, ON4 price has a max estimate of 10.48 EUR and a min estimate of 7.57 EUR. Watch ON4 chart and read a more detailed ONO Pharmaceutical Co., Ltd. stock forecast: see what analysts think of ONO Pharmaceutical Co., Ltd. and suggest that you do with its stocks.
ON4 reached its all-time high on Jul 14, 2022 with the price of 27.600 EUR, and its all-time low was 8.950 EUR and was reached on Jul 8, 2025. View more price dynamics on ON4 chart.
See other stocks reaching their highest and lowest prices.
ON4 stock is 1.04% volatile and has beta coefficient of 0.34. Track ONO Pharmaceutical Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is ONO Pharmaceutical Co., Ltd. there?
Today ONO Pharmaceutical Co., Ltd. has the market capitalization of ‪4.64 B‬, it has decreased by −0.60% over the last week.
Yes, you can track ONO Pharmaceutical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
ONO Pharmaceutical Co., Ltd. is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
ON4 earnings for the last quarter are 0.22 EUR per share, whereas the estimation was 0.29 EUR resulting in a −23.95% surprise. The estimated earnings for the next quarter are 0.25 EUR per share. See more details about ONO Pharmaceutical Co., Ltd. earnings.
ONO Pharmaceutical Co., Ltd. revenue for the last quarter amounts to ‪751.26 M‬ EUR, despite the estimated figure of ‪702.29 M‬ EUR. In the next quarter, revenue is expected to reach ‪700.89 M‬ EUR.
ON4 net income for the last quarter is ‪103.61 M‬ EUR, while the quarter before that showed ‪−40.33 M‬ EUR of net income which accounts for 356.91% change. Track more ONO Pharmaceutical Co., Ltd. financial stats to get the full picture.
ONO Pharmaceutical Co., Ltd. dividend yield was 4.99% in 2024, and payout ratio reached 75.08%. The year before the numbers were 3.26% and 30.01% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 2, 2025, the company has ‪4.29 K‬ employees. See our rating of the largest employees — is ONO Pharmaceutical Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ONO Pharmaceutical Co., Ltd. EBITDA is ‪512.84 M‬ EUR, and current EBITDA margin is 18.54%. See more stats in ONO Pharmaceutical Co., Ltd. financial statements.
Like other stocks, ON4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONO Pharmaceutical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ONO Pharmaceutical Co., Ltd. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ONO Pharmaceutical Co., Ltd. stock shows the sell signal. See more of ONO Pharmaceutical Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.